LAW OF THE AZERBAIJAN REPUBLIC

of October 14, 2016 No. 360-VQD

About introduction of amendments to the Law of the Azerbaijan Republic "About medicines"

Being guided by Item 11 of part I of article 94 of the Constitution of the Azerbaijan Republic, Millie decides Majlis of the Azerbaijan Republic:

In the Law of the Azerbaijan Republic "About medicines" (Collection of the legislation of the Azerbaijan Republic, 2007, No. 2, Article 70, No. 11, Article 1046; 2009, No. 6, Article 397, No. 12, Articles 948, 949; 2010, No. 7, Article 600; 2011, No. 4, Article 259; 2013, No. 4, Article 356; 2015, No. 2, Article 84, No. 4, Article 365) to make the following changes:

1. At the end of Article 1.0.17 to replace point with semicolon and to add with Articles 1.0.18 - 1.0.20 following of content:

"1.0.18. equivalent medicines - medicines with identical active ingredient (substances), pharmaceutical form and single amount (dose) of raw substance;

1.0.19. analog medicines - medicines which have identical active ingredient (substances), pharmaceutical form, but differ by single amount (dose) of raw substance and (or) quantity of units in packaging;

1.0.20. biologically active nutritional supplements - the products with the established dose for daily acceptance made in pharmaceutical form of the bioactive agents of plant, animal, mineral origin or bioactive agents received in the chemical way and their complexes for the purpose of enrichment of diet.".

2. Add with Articles 4. 7, 16.4 and 14-1 following contents:

"4.7. Sale of the medicines which underwent state registration without price regulation or their sale at the prices different from the settled prices is forbidden (except for the prices which are lower than wholesale prices and are offered in case of public procurements and to medical institutions).

16.4. Producers of medicines, local representative offices (branches) of foreign producers or persons authorized by them shall provide to relevant organ of the executive authority of the declaration, reporting documents and necessary data for the purpose of price regulation on the medicines which underwent state registration.

Disclaimer! This text was translated by AI translator and is not a valid juridical document. No warranty. No claim. More info